Cartesian Therapeutics, Inc. Restricted Cash and Cash Equivalents
Cartesian Therapeutics, Inc. (RNAC) had Restricted Cash and Cash Equivalents of $1.70 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-08-06
- 2026-06-30: Restricted Cash and Cash Equivalents $1.70M.
- 2026-03-31: Restricted Cash and Cash Equivalents $1.70M.
- 2025-12-31: Restricted Cash and Cash Equivalents $1.70M.
- 2025-09-30: Restricted Cash and Cash Equivalents $1.70M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2026-06-30 | $1.70M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.70M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $1.70M 10-K · filed 2026-03-09 |
| 2025-09-30 | $1.70M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.70M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.70M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.70M 10-K · filed 2025-03-13 |
| 2024-09-30 | $1.70M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.70M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.40M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.40M 10-K · filed 2024-03-07 |
| 2023-09-30 | $1.40M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $3.00M 10-Q · filed 2023-08-17 |
| 2023-03-31 | $1.60M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.60M 10-K · filed 2023-03-02 |
| 2022-09-30 | $1.60M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.40M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.40M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.40M 10-K · filed 2022-03-10 |
| 2021-09-30 | $1.40M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.40M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.40M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.40M 10-K · filed 2021-03-12 |
| 2020-09-30 | $1.40M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.70M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.70M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.70M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |